Henan Lingrui Pharmaceutical Co Ltd (600285) — Long-term Investment Intensity

Latest as of September 2019: 11.1%

Henan Lingrui Pharmaceutical Co Ltd (600285) has a Long-term Investment Intensity of 11.1% as of September 2019. Long-term investments of CN¥382.73 Million represent 11.1% of total assets of CN¥3.45 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 600285 cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

11.1%
LT Investments / Total Assets

Long-term Investments

CN¥382.73 Million
CNY

Total Assets

CN¥3.45 Billion
CNY

Country

China
SHG

Henan Lingrui Pharmaceutical Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Henan Lingrui Pharmaceutical Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 11.1%, reflecting long-term investments of CN¥382.73 Million against total assets of CN¥3.45 Billion CNY. For the complete balance sheet picture, see 600285 total asset value.

Annual Long-term Investment Intensity for Henan Lingrui Pharmaceutical Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Henan Lingrui Pharmaceutical Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Henan Lingrui Pharmaceutical Co Ltd (600285) financial obligations for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 8.9% CN¥278.14 Million CN¥3.11 Billion ▼ -3.6 pp
2017 12.5% CN¥413.34 Million CN¥3.31 Billion ▲ +0.2 pp
2016 12.3% CN¥367.25 Million CN¥2.98 Billion ▼ -17.6 pp
2015 29.9% CN¥811.08 Million CN¥2.71 Billion
pp = percentage points